Diseases, Conditions, Syndromes

US syphilis cases continue to climb

U.S. cases of syphilis have soared past numbers seen just a decade ago, new government statistics show. The grim numbers are for 2022, the latest year for which an accurate tally is available.

Medications

Q&A: DoxyPEP, a 'morning-after pill' for STIs

There has been an alarming increase in sexually transmitted infections in the U.S. over the past decade: In 2021 alone, 2.53 million cases of chlamydia, gonorrhea, and syphilis were recorded, a 7% increase from 2017—and ...

Medications

Combined antibiotics more effective against Lyme disease: Study

Researchers at Tulane University have found that a combination of antibiotics is more effective in treating Lyme disease than the commonly prescribed course of one single antibiotic. This finding, published in Frontiers in ...

HIV & AIDS

Global AIDS fight at crossroads after setbacks during COVID

Hard-won progress against HIV has stalled, putting millions of lives at risk, according to an alarming report Wednesday on how the COVID-19 pandemic and other global crises are jeopardizing efforts to end AIDS.

page 1 from 4

Doxycycline

Doxycycline INN ( /ˌdɒksɨˈsaɪkliːn/ doks-i-sy-kleen) is a member of the tetracycline antibiotics group, and is commonly used to treat a variety of infections. Doxycycline is a semisynthetic tetracycline invented and clinically developed in the early 1960s by Pfizer Inc.[citation needed] and marketed under the brand name Vibramycin.[citation needed] Vibramycin received U.S. Food and Drug Administration (FDA) approval in 1967,[citation needed] becoming Pfizer's first once-a-day, broad-spectrum antibiotic.[citation needed] Other brand names include Monodox, Microdox, Periostat, Vibra-Tabs, Oracea, Doryx, Vibrox, Adoxa, Doxyhexal, Doxylin, Doxoral,Doxy-1 and Atridox (topical doxycycline hyclate for periodontitis).

This text uses material from Wikipedia, licensed under CC BY-SA